{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:13:56Z","timestamp":1761844436437,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Japanese Ministry of Health and Labour Science Research"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.jiac.2014.10.006","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T19:24:18Z","timestamp":1416511458000},"page":"84-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Comparison of cystatin C and creatinine to determine the incidence of composite adverse outcomes in HIV-infected individuals"],"prefix":"10.1016","volume":"21","author":[{"given":"Naoki","family":"Yanagisawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shugo","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Suganuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akifumi","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Ajisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2014.10.006_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2010.483","article-title":"The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report","volume":"80","author":"Levey","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.jiac.2014.10.006_bib2","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","journal-title":"Kidney Int Suppl."},{"key":"10.1016\/j.jiac.2014.10.006_bib3","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1681\/ASN.2008070730","article-title":"Combining GFR and albuminuria to classify CKD improves prediction of ESRD","volume":"20","author":"Hallan","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jiac.2014.10.006_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.CIR.0000133312.96477.48","article-title":"Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes","volume":"110","author":"Klausen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jiac.2014.10.006_bib5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/jama.2010.39","article-title":"Relation between kidney function, proteinuria, and adverse outcomes","volume":"303","author":"Hemmelgarn","year":"2010","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.jiac.2014.10.006_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-154-1-201101040-00003","article-title":"Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort study","volume":"154","author":"Tonelli","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2014.10.006_bib7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/ajkd.2002.34487","article-title":"Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis","volume":"40","author":"Dharnidharka","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jiac.2014.10.006_bib8","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa043161","article-title":"Cystatin C and the risk of death and cardiovascular events among elderly persons","volume":"352","author":"Shlipak","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2014.10.006_bib9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.7326\/0003-4819-145-4-200608150-00003","article-title":"Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease","volume":"145","author":"Shlipak","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2014.10.006_bib10","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1681\/ASN.2004100854","article-title":"Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study","volume":"16","author":"Perkins","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jiac.2014.10.006_bib11","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1214234","article-title":"Cystatin C versus creatinine in determining risk based on kidney function","volume":"369","author":"Shlipak","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2014.10.006_bib12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/00365519850186210","article-title":"Serum cystatin C as a marker of the renal function","volume":"58","author":"Randers","year":"1998","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.jiac.2014.10.006_bib13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1053\/ajkd.2001.20628","article-title":"Serum cystatin C concentration as a marker of renal dysfunction in the elderly","volume":"37","author":"Fliser","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jiac.2014.10.006_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2004.09.025","article-title":"Cystatin C as a marker of GFR\u2013history, indications, and future research","volume":"38","author":"Filler","year":"2005","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jiac.2014.10.006_bib15","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1053\/j.ajkd.2010.05.019","article-title":"Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons","volume":"56","author":"Choi","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jiac.2014.10.006_bib16","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1001\/archinte.167.20.2213","article-title":"Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study","volume":"167","author":"Odden","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jiac.2014.10.006_bib17","doi-asserted-by":"crossref","first-page":"362","DOI":"10.5414\/CN107668","article-title":"Impact of cystatin C elevation and albuminuria on probability of adverse outcomes in HIV-infected men receiving HAART","volume":"79","author":"Yanagisawa","year":"2013","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jiac.2014.10.006_bib18","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1097\/QAD.0b013e3282ef1bb4","article-title":"Chronic kidney disease in HIV infection: an urban epidemic","volume":"21","author":"Wyatt","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.jiac.2014.10.006_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/MAJ.0b013e31812e6b34","article-title":"Prevalence of chronic kidney disease in an urban HIV infected population","volume":"335","author":"Fernando","year":"2008","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jiac.2014.10.006_bib20","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1093\/ndt\/gfm350","article-title":"Prevalence of chronic kidney disease in Chinese HIV-infected patients","volume":"22","author":"Cheung","year":"2007","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.jiac.2014.10.006_bib21","doi-asserted-by":"crossref","first-page":"c285","DOI":"10.1159\/000322278","article-title":"Clinical characteristics of kidney disease in Japanese HIV-infected patients","volume":"118","author":"Yanagisawa","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.jiac.2014.10.006_bib22","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/QAD.0b013e3280f774ee","article-title":"Chronic renal failure among HIV-1-infected patients","volume":"21","author":"Mocroft","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.jiac.2014.10.006_bib23","article-title":"Classification of human immunodeficiency virus-infected patients with chronic kidney disease using a combination of proteinuria and estimated glomerular filtration rate","author":"Yanagisawa","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.jiac.2014.10.006_bib24","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/aje\/kwp151","article-title":"Defining incident chronic kidney disease in the research setting: the ARIC Study","volume":"170","author":"Bash","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jiac.2014.10.006_bib25","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/ndt\/gfq787","article-title":"Serum phosphate but not pulse wave velocity predicts decline in renal function in patients with early chronic kidney disease","volume":"26","author":"Chue","year":"2011","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.jiac.2014.10.006_bib26","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jiac.2014.10.006_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1053\/j.ajkd.2012.07.007","article-title":"GFR estimation using standardized serum cystatin C in Japan","volume":"61","author":"Horio","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jiac.2014.10.006_bib28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10157-006-0458-z","article-title":"Clinical utility of trace proteinuria for microalbuminuria screening in the general population","volume":"11","author":"Konta","year":"2007","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.jiac.2014.10.006_bib29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1681\/ASN.2010050483","article-title":"Cystatin C identifies chronic kidney disease patients at higher risk for complications","volume":"22","author":"Peralta","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jiac.2014.10.006_bib30","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.amjmed.2005.07.060","article-title":"Cystatin-C and inflammatory markers in the ambulatory elderly","volume":"118","author":"Shlipak","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.jiac.2014.10.006_bib31","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/j.1523-1755.2004.00517.x","article-title":"Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement","volume":"65","author":"Knight","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.jiac.2014.10.006_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7326\/0003-4819-147-1-200707030-00004","article-title":"Cystatin C as a risk factor for outcomes in chronic kidney disease","volume":"147","author":"Menon","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2014.10.006_bib33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/archinternmed.2007.40","article-title":"Cystatin C and aging success","volume":"168","author":"Sarnak","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jiac.2014.10.006_bib34","doi-asserted-by":"crossref","first-page":"497","DOI":"10.7326\/0003-4819-142-7-200504050-00008","article-title":"Cystatin C concentration as a risk factor for heart failure in older adults","volume":"142","author":"Sarnak","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2014.10.006_bib35","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1053\/j.ajkd.2013.03.027","article-title":"Update on cystatin C: incorporation into clinical practice","volume":"62","author":"Shlipak","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jiac.2014.10.006_bib36","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection","volume":"5","author":"Kuller","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.jiac.2014.10.006_bib37","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection","volume":"201","author":"Neuhaus","year":"2010","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jiac.2014.10.006_bib38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/QAD.0b013e32831cc129","article-title":"Interruption of antiretroviral therapy is associated with increased plasma cystatin C","volume":"23","author":"Mocroft","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.jiac.2014.10.006_bib39","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1177\/135965350801300810","article-title":"Cystatin C as a marker of renal function is affected by HIV replication leading to an underestimation of kidney function in HIV patients","volume":"13","author":"Mauss","year":"2008","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jiac.2014.10.006_bib40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/QAI.0b013e3181e674f4","article-title":"The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women","volume":"55","author":"Estrella","year":"2010","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jiac.2014.10.006_bib41","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3851\/IMP1766","article-title":"Pre-existing albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy","volume":"16","author":"Wyatt","year":"2011","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jiac.2014.10.006_bib42","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/CIRCULATIONAHA.109.898585","article-title":"Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons","volume":"121","author":"Choi","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jiac.2014.10.006_bib43","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1093\/ndt\/gfr129","article-title":"Urinary albumin excretion within the normal range is an independent risk for near-term development of kidney disease in HIV-infected patients","volume":"26","author":"Ando","year":"2011","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.jiac.2014.10.006_bib44","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1086\/430257","article-title":"Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America","volume":"40","author":"Gupta","year":"2005","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X14003596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X14003596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:53:41Z","timestamp":1761159221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X14003596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1341321X14003596"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2014.10.006","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of cystatin C and creatinine to determine the incidence of composite adverse outcomes in HIV-infected individuals","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2014.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}